← Leaderboard
GMAB
Ticker
GMAB
Congressional Trades
4
by 1 members
Ticker Intelligence Brief
Who in Congress traded GMAB, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Latest receipt
Josh Gottheimer
BUY · 2025-01-16
Largest range
$1K – $15K
Josh Gottheimer
Slowest filing
29d
Josh Gottheimer
Best vs SPY
21.1%
Josh Gottheimer
Buys
2
50%
Sells
2
50%
Total Volume
$32K
midpoint
Unique Traders
1
members
Party Breakdown
Democrats4 · 100%
Republicans0 · 0%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthALIGNEDBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
0▲1▼
Jun '24
—
1▲
Jul '24
—
0▲1▼
Dec '24
—
1▲
Jan '25
—
Democrats2▲2▼Neutral
vs
Republicans0▲0▼Neutral
Net buyingNet selling⚡ Party split
💼 Lobbying Filings
all →- 2026-04-20$60KGENMABPrescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. 340B Issues.
- 2026-04-15$60KGENMAB US INC.
- 2026-01-20$60KGENMABGeneral Medicare/Medicaid Issues. 340B Issues. Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022.
- 2026-01-14$60KGENMAB US INC.
- 2025-10-15$60KGENMAB US INC.Guidance on legislation and regulations regarding the creation and development of differentiated antibody therapeutics.
- 2025-10-12$60KGENMABPrescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. 340B Issues.
- 2025-07-19$60KGENMABPrescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. 340B Issues.
- 2025-07-15$60KGENMAB US INC.Guidance on legislation and regulations regarding the creation and development of differentiated antibody therapeutics.
- 2025-04-21$60KGENMABPrescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. Safe STEP Act. 340B Issues.
- 2025-04-15$60KGENMAB US INC.Guidance on legislation and regulations regarding the creation and development of differentiated antibody therapeutics.
Congressional Momentum
buy vs. sell pressureNEUTRALScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
No trades
All-Time
–50
2 buys4 total2 sells
$16K buys · $16K sells
Cumulative Net Position (buy vol − sell vol)
+$0
2024-064 trades plotted2025-01
Trade Activity Timeline
Congressional buys & sells by month · last 4 months w/ activity
24/06
24/07
24/12
25/01
BuysSellsOtherHigh-volume month
Seasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Net buyingNet sellingNo trades · number = trade count
Peak buy month: Jan · Peak sell month: Jun
Congressional Conviction Timeline
net positioning · alpha track recordMIXED2 buys2 sellscumulative α -19.5%4mo tracked
Monthly Net Flow (Buys − Sells)
Cumulative Excess Return on Congressional Buys vs SPY
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2025-01-16 | DJosh Gottheimer | BUY | $1K – $15K | 25d | receipt → |
| 2024-12-16 | DJosh Gottheimer | SELL | $1K – $15K | 29d | receipt → |
| 2024-07-19 | DJosh Gottheimer | BUY | $1K – $15K | 27d | receipt → |
| 2024-06-18 | DJosh Gottheimer | SELL | $1K – $15K | 21d | receipt → |